Company performance
Add to research
Current Price
as of Apr 21, 2025$10.91
P/E Ratio
10.85
Market Cap
$634.25M
Description
Add to research
Embecta Corp. engages in the provision of medical devices used in the treatment of diabetes. Its products include pen needles, syringes, and safety devices complemented by a digital application. The company was founded in 1924 and is headquartered in Parsippany, NJ.
Metrics
Add to research
Overview
- HQParsippany, NJ
- SectorHealth Technology
- IndustryMedical Specialties
- TickerEMBC
- Price$10.91-3.79%
Trading Information
- Market cap$634.25M
- Float92.12%
- Average Daily Volume (1m)601,118
- Average Daily Volume (3m)583,940
- EPS$1.01
Company
- Revenue$1.11B
- Rev growth (1yr)-5.55%
- Net incomeN/A
- Gross margin59.03%
- EBITDA margin24.93%
- EBITDA$65.30M
- EV$2.59B
- EV/Revenue2.33
- P/E10.85
- P/S0.58
- P/BN/A
- Debt/EquityN/A
Documents
Add to research
SEC Filings
Earnings Calls
Factset Street Account